Gridlock from Diagnosis to Treatment of Multidrug Resistant Tuberculosis in Tanzania: Patients Perspectives from the Focus Group Discussion
S. G. Mpagama, E. Mangi, P. M. Mbelele, A. M. Chongolo, G. S. Kibiki, S. K. Heysell
Abstract
IntroductionMolecular diagnostics have revolutionized the diagnosis of multidrug resistant tuberculosis (MDR-TB). Yet in Tanzania we found delay in diagnosis with more than 70% of MDR-TB patients having history of several previous treatment courses for TB signaling complications of prior missed diagnosis. We aimed to explore patients viewpoints and experiences with personal and socio-behavioral obstacles from MDR-TB diagnosis to treatment in an attempt to understand these prior findings.\n\nMethodsThe study was conducted in December 2016 with MDR-TB patients admitted at Kibongoto Infectious Diseases Hospital. We used semi-structured interviews and focus group discussion to examine patients views and experiences during MDR-TB diagnosis. Groups were sex aggregated to allow free interaction and to gauge gender specific issues in the social and behavioral contexts. The discussion - explored patients delivery factors that were impacting delay from MDR-TB diagnosis to treatment. Iterative data collection and analysis was applied with data, codes and categories being compared and refined.\n\nResultsForty-five MDR-TB patients participated in 6 focus group discussions. Challenges and barriers contributing to the delay from MDR-TB diagnosis to treatment were as follows: 1) The general population had differing understanding of MDR-TB that led to seeking services from traditional healers; 2) Also socio-economic adversity made health-seeking behavior difficult and often unproductive; 3) In the health system, challenges included inadequacy of MDR-TB diagnostic centers, lack of knowledge on behalf of health care providers to consider MDR-TB and order appropriate diagnostics; 4) Insufficiency in the specimen referral system for early diagnosis of MDR-TB. Non-adherence of TB patients to first-line anti-TB drugs prior to MDR-TB diagnosis given the multitude of barriers discussed was coupled with both intentional and unintentional non-adherence of health care providers to international standards of TB care.\n\nConclusionPatient-centered strategies bridging communities and the health system are urgently required for optimum MDR-TB control in Tanzania.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Resistance Rate Distribution of MDR-TB Among Pulmonary Tuberculosis Patients Attending Nnamdi Azikiwe University Teaching Hospital Nnewi and ST Patrick’S Hospital Mile 4 Abakiliki in Southeast Nigeria
C. E. Okoro, C. N. Akujobi, … A. C. Okpe·bioRxiv·Mar 9, 2019
- Prediction of multiple drug resistant pulmonary tuberculosis against drug sensitive pulmonary tuberculosis by CT nodular consolidation sign
X.-L. Huang, A. Skrahin, … Y.-X. Wang·bioRxiv·Nov 7, 2019
- Extensive endemic transmission of multidrug resistant Mycobacterium tuberculosis in Bhutan: A retrospective genomic-epidemiological study
Thinley Dorji, Karchung Tshering, … Patiyan Andersson·Open Forum Infectious DiseasesPeer-reviewed·Dec 26, 2025
- Multi-clonal evolution of MDR/XDR M. tuberculosis in a high prevalence setting in Papua New Guinea over three decades
Arnold Bainomugisa, Evelyn Lavu, … Lachlan J. M. Coin·bioRxiv·Aug 4, 2017
- Cycloserine for Treatment of Multidrug-Resistant Tuberculosis in China: A Retrospective Observational Study
Yang Li, Fei Wang, … Wenhong Zhang·bioRxiv·Apr 25, 2018
- Within-host evolution of drug tolerance in Mycobacterium tuberculosis.
Valerie F. A. March, Kakha Mchedlishvili, … Sònia Borrell·JAC-Antimicrobial ResistancePeer-reviewed·Jan 7, 2026